Rejection and recipient age

Area of Science:

• Transplantation immunology
• Geriatric medicine

Background:

• Acute rejection risk in organ transplantation decreases with recipient age.
• This age-related decline is evident in non-vascularised (corneal) and vascularised (kidney) transplants.
• However, in vascularised transplants, the benefit is masked by increased chronic allograft nephropathy and mortality from infections and drug toxicity in older recipients.

Purpose of the Study:

• To explore the cellular mechanisms behind age-related weakening of transplant rejection.
• To discuss the implications for immunosuppressive drug therapy in elderly transplant recipients.
• To highlight the need for assays to personalize immunosuppression based on individual patient response.

Main Methods:

• Review of existing literature on age-related changes in immune response post-transplantation.
• Analysis of cellular mechanisms, including signal transduction pathways.
• Discussion of pharmacokinetic data and lack of routine efficacy assays for immunosuppressive drugs.

Main Results:

• Decreased acute rejection in older recipients is linked to immunosenescence.
• Defective signal transduction leads to reduced immune cell activation in elderly individuals.
• Elderly recipients show decreased resistance to immunosuppressive drugs, suggesting a need for less intensive therapy.

Conclusions:

• The decline in acute rejection with increasing recipient age is attributed to both immunosenescence and reduced drug efficacy.
• Less intensive immunosuppressive drug regimens may be suitable for elderly transplant recipients.
• Development of future assays to measure drug efficacy in individual patients is crucial for tailoring therapy.